Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
OHSU Knight Cancer Institute
City of Hope Medical Center
Xiangya Hospital of Central South University
Oslo University Hospital
University of Florida
Massachusetts General Hospital
M.D. Anderson Cancer Center
Swiss Cancer Institute
Sarcoma Alliance for Research through Collaboration
Translational Oncology Research International
Peking University Cancer Hospital & Institute
Duke University
Duke University